Sign in to view content

Genetic Variants Associated With Anti-VEGF Drug Response in Neovascular AMD Patients in the View Trial

Nancy M. Holekamp, MD, FASRS

Video
Published 2016

Related

New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2022
Wet AMD 3 Symposium
Annual Meeting Talks
2020
Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME
Seenu M. Hariprasad, MD
On Demand Cases, Courses, and Papers
2018

Category: Diabetic Retinopathy

See more